
JNPC Pharma Innovation Limited
About JNPC Pharma Innovation Limited
Data last updated:
JNPC Pharma Innovation Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Ramky Pharma City (India) Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2011PLC077628.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Yancharla Rathnakara Nagaraja and Popuri Pandari Lal Krishna.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ramky Grandiose 15th Floor Sy No 136/2 & 4 Gachibowli, Hyderabad, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹1 Lakh (net margin 62.5%) and EBITDA of ₹1.4 Lakh (EBITDA margin 87.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹10 Lakh; the latest was in March 2014.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
JNPC Pharma Innovation has one previous CIN (Corporate Identification Number): U73100AP2011PLC077628. The current CIN is U73100TG2011PLC077628, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2011PLC077628 | Current |
| U73100AP2011PLC077628 | Previous |
Contact details
JNPC Pharma Innovation Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRamky Grandiose 15th Floor Sy No 136/2 & 4 Gachibowli, Hyderabad, Telangana, India – 500032
- IndustryPharma, Pharma Contract R&D
To see the full contact details of JNPC Pharma Innovation Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of JNPC Pharma Innovation Limited
FY 2025 filings availableJNPC Pharma Innovation Limited reported revenue of ₹1.6 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 30% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 87.5% | ||||
| Net Profit Margin | 62.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of JNPC Pharma Innovation Limited, buy the company report.
Board of directors of JNPC Pharma Innovation Limited
JNPC Pharma Innovation has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yancharla Rathnakara Nagaraja Also directs: Ramky Infrastructure Limited, Mallannasagar Water Supply Limited, Maha Integrated Life Sciences City Limited and 5 more | Director | 03 Jul 2021 | 5 Years 4 Months | Current |
| Popuri Pandari Lal Krishna Also directs: Visakha Pharmacity Limited, Receps Limited, Eco Carbon Engineering Solutions Limited and 3 more | Director | 21 Jan 2013 | 13 Years 9 Months | Current |
| Pakanati Venkata Raghava Reddy Also directs: Eco Carbon Engineering Solutions Limited, Visakha Energy Limited, Visakha Pharma Innovation and Incubation Limited and 5 more | Director | 05 Feb 2024 | 2 Years 9 Months | Current |
Auditor
JNPC Pharma Innovation Limited is audited by Visweswararao & Associates for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Visweswararao & Associates | FY 2016 | 005774S |
Shareholding
The shareholding of JNPC Pharma Innovation Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of JNPC Pharma Innovation Limited, buy the company report.
Deals & funding
JNPC Pharma Innovation Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹10 Lakh; the latest was in March 2014.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Visakha Pharmacity Limited Seller: Smilax Laboratories Limited |
| Feb 2012 | Funding round | ₹10 Lakh | Investors: Smilax Laboratories Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
JNPC Pharma Innovation Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Court case (CMSA) | Filed against the company by M/S. Jagati Publication Ltd | Pending |
To see the full case history of JNPC Pharma Innovation Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for JNPC Pharma Innovation Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for JNPC Pharma Innovation Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
JNPC Pharma Innovation Limited has 14 board changes on record since 2012: 3 appointments and 11 cessations. The latest: Pakanati Venkata Raghava Reddy ceased to be Additional Director on 06 Sep 2024.
5 earlier events are in the company report.
Frequently asked questions
JNPC Pharma Innovation is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 November 2011 (15+ years old) and is registered under CIN U73100TG2011PLC077628.
JNPC Pharma Innovation has 3 current directors:
- Yancharla Rathnakara Nagaraja - Director
- Popuri Pandari Lal Krishna - Director
- Pakanati Venkata Raghava Reddy - Director
The latest financial statements of JNPC Pharma Innovation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of JNPC Pharma Innovation is U73100TG2011PLC077628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JNPC Pharma Innovation has 1 court case on record: 1 filed against it. 1 is pending.
JNPC Pharma Innovation was incorporated on 23 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
JNPC Pharma Innovation has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹10 Lakh; the latest was in March 2014.
Pakanati Venkata Raghava Reddy ceased to be Additional Director on 06 Sep 2024. Pakanati Venkata Raghava Reddy was appointed as Director on 05 Feb 2024. Ajay Kumar Masand ceased to be Additional Director on 29 Sep 2023. JNPC Pharma Innovation has 14 board changes on record in total.
The registered office of JNPC Pharma Innovation is at Ramky Grandiose 15th Floor Sy No 1362 & 4 Gachibowli, Hyderabad, Telangana, India – 500032.
JNPC Pharma Innovation operates in the pharma industry, in the pharma contract r and d segment.

